|Articles|March 19, 2008

DEA exempts six anabolic steroid products from its regulatory control

The Drug Enforcement Administration is moving three anabolic steroid products out of Schedule III status.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!

Related Content